[mailpoet_sector_follow]

US Broker Ratings

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Navigating the Growth Path with a 21.5% Revenue Surge

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is making waves in the healthcare sector with its cutting-edge immune medicine platform, designed to revolutionize diagnostics and treatment for a..

Immunocore Holdings plc (IMCR) Stock Analysis: Uncovering an 87% Upside Potential in Biotechnology

Immunocore Holdings plc (NASDAQ: IMCR), a UK-based biotechnology firm, is gaining attention in the investor community with a significant potential upside of 87.27%. This prospective growth..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Biotechnology Firm with 14% Upside Potential

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a promising name in the biotechnology sector, is catching the attention of investors with a substantial market capitalization of $4.84 billion...

agilon health, inc. (AGL) Stock Analysis: Navigating the Healthcare Sector with a 13.42% Potential Upside

agilon health, inc. (AGL) stands as a noteworthy player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.63..

NeoGenomics, Inc. (NEO) Stock Analysis: Why Investors Should Consider the 18.59% Potential Upside

NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the healthcare sector, is capturing the attention of investors with its impressive 18.59% potential upside. As a leader..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a 34.77% Potential Upside

Astrana Health Inc. (NASDAQ: ASTH) is drawing attention in the healthcare sector with its robust revenue growth and promising potential upside, making it a compelling consideration..

MiMedx Group, Inc (MDXG) Stock Report: Exploring a 63.93% Potential Upside in the Biotech Arena

MiMedx Group, Inc. (NASDAQ: MDXG) presents a compelling opportunity for investors seeking exposure in the biotechnology sector. With a market capitalization of $622.4 million, this U.S.-based..

Integra LifeSciences Holdings C (IART) Investor Outlook: Assessing the 14.56% Potential Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART) has captured the attention of investors looking for opportunities in the healthcare sector, specifically within medical devices. With a market..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Unpacking a Potential 124.71% Upside in Biotech

Janux Therapeutics, Inc. (NASDAQ: JANX), a burgeoning player in the biotechnology sector, has caught the attention of investors with the potential for a 124.71% upside based..

Novavax, Inc. (NVAX) Stock Analysis: Growth Potential Amidst a 77% Upside

Novavax, Inc. (NVAX), a prominent player in the biotechnology sector, has garnered significant attention from investors, thanks to its promising potential upside of 77.47%, as indicated..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Exploring a 214% Upside in Biotech’s Future

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based biotechnology company, is capturing investor attention with its innovative approach to RNA medicine and a potential upside of..

Pacira BioSciences, Inc. (PCRX) Investor Outlook: Navigating a 22.80% Potential Upside in Non-Opioid Solutions

Pacira BioSciences, Inc. (NASDAQ: PCRX) is a notable entity in the healthcare sector, particularly within the specialized field of non-opioid pain management. With a market capitalization..

Progyny, Inc. (PGNY) Stock Analysis: Examining the 21% Potential Upside

Progyny, Inc. (NASDAQ: PGNY), a leader in the healthcare plans sector, is drawing significant investor attention with its robust growth potential and unique positioning within the..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: 23% Upside Potential Sparks Investor Interest

Healthcare Services Group, Inc. (NASDAQ: HCSG), a prominent player in the Medical Care Facilities sector, is garnering attention from investors due to a compelling potential upside..

Indivior Pharmaceuticals, Inc. (INDV) Stock Analysis: Exploring a 27% Potential Upside Amid Strong Revenue Growth

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV), a prominent player in the healthcare sector, has captured investor attention with its robust focus on addressing opioid dependence through its..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Unveiling a Compelling 36% Upside Potential

Establishment Labs Holdings Inc (NASDAQ: ESTA) is making waves in the healthcare sector with its innovative approach to medical devices, particularly in the realm of breast..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Eyeing a 352% Potential Upside in Biotechnology

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) is currently capturing the attention of investors with a remarkable potential upside of 352.62%, making it a compelling opportunity in the..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 78.96% Potential Upside in the Biotech Sector

Investors with an eye on the healthcare sector should take a closer look at Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a promising player in the biotechnology industry...

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Biotech Growth Potential with 17.78% Upside

Travere Therapeutics, Inc. (TVTX), a prominent player in the biotechnology sector, is generating considerable interest among investors, particularly those focused on the healthcare space. With a..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Growth Potential Amid Strong Revenue Growth and Analyst Confidence

Aveanna Healthcare Holdings Inc (AVAH), a significant player in the healthcare sector, is drawing investor attention with its robust revenue growth and strong analyst confidence. With..

Search

Funds

FTSE 250

Search

Funds

US Broker Ratings

FTSE 100

Funds